Literature DB >> 11755405

Introduction: microbiology and immunology: lessons learned from Salmonella.

S H Kaufmann1, B Raupach, B B Finlay.   

Abstract

Salmonella enterica, a Gram-negative bacterium, causes significant morbidity and mortality worldwide, and is an excellent model to study bacterial pathogenesis and cellular immune responses. With the development of powerful new technologies, there has been a fusion of research on immunology, molecular biology and cellular microbiology of S. enterica infections. This multidisciplinary research will enhance our understanding of the basic mechanisms of bacterial infections and immunity; it also provides new approaches towards therapeutic and control measures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755405     DOI: 10.1016/s1286-4579(01)01498-8

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

1.  Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice.

Authors:  Gábor Nagy; Ulrich Dobrindt; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection.

Authors:  Freddy A Medina; Cecilia J de Almeida; Elliott Dew; Jiangwei Li; Gloria Bonuccelli; Terence M Williams; Alex W Cohen; Richard G Pestell; Philippe G Frank; Herbert B Tanowitz; Michael P Lisanti
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

3.  Lipopolysaccharides belonging to different Salmonella serovars are differentially capable of activating Toll-like receptor 4.

Authors:  Daniela Chessa; Luisella Spiga; Nicola De Riu; Paola Delaconi; Vittorio Mazzarello; Giulia Ganau; Salvatore Rubino
Journal:  Infect Immun       Date:  2014-08-18       Impact factor: 3.441

4.  Salmonella enterica serovar Typhimurium-induced placental inflammation and not bacterial burden correlates with pathology and fatal maternal disease.

Authors:  Anindita Chattopadhyay; Nirmal Robinson; Jagdeep K Sandhu; B Brett Finlay; Subash Sad; Lakshmi Krishnan
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

Review 5.  Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.

Authors:  Vafa Shahabi; Paulo C Maciag; Sandra Rivera; Anu Wallecha
Journal:  Bioeng Bugs       Date:  2010-01-04

6.  Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium.

Authors:  Rachel A Luu; Komal Gurnani; Renu Dudani; Rajagopal Kammara; Henk van Faassen; Jean-Claude Sirard; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).

Authors:  Marsha S Russell; Monica Iskandar; Oksana L Mykytczuk; John H E Nash; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines.

Authors:  Tie Liu; Rolf König; Jian Sha; Stacy L Agar; Chien-Te K Tseng; Gary R Klimpel; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-06       Impact factor: 3.738

9.  Pathogen proliferation governs the magnitude but compromises the function of CD8 T cells.

Authors:  Subash Sad; Renu Dudani; Komal Gurnani; Marsha Russell; Henk van Faassen; Brett Finlay; Lakshmi Krishnan
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

10.  Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium.

Authors:  Heidrun Koebernick; Leander Grode; John R David; Wolfgang Rohde; Michael S Rolph; Hans-Willi Mittrücker; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.